Peri-implantitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Dental Clinics is the fastest growing sector, North America is the largest market

The Global Peri-implantitis Market is projected to grow substantially from USD 11.02 billion in 2025 to USD 17.67 billion by 2031, at an 8.19% Compound Annual Growth Rate. Peri-implantitis is a pathological inflammatory condition characterized by soft tissue inflammation and the progressive loss of supporting bone around a dental implant. The market's primary driver is the increasing global volume of dental implant procedures, fueled by an aging population and rising rates of edentulism. As the cumulative number of placed implants increases, the incidence of biological complications like peri-implantitis naturally rises, creating a sustained demand for diagnostic and therapeutic solutions. For example, approximately three million individuals in the United States had dental implants in 2025, according to the American Academy of Implant Dentistry, representing a significant patient pool susceptible to this disease.

Market Drivers

The expanding volume of dental implant procedures serves as the main catalyst for the Global Peri-implantitis Market, as the rising count of placed implants directly correlates with a higher incidence of biological complications, thereby increasing the patient pool requiring therapeutic intervention. This trend is underscored by robust financial results from key industry players, signaling continued growth in implant therapy.

Concurrently, technological advancements in regenerative and laser therapies are propelling market expansion by providing clinicians with more predictable and efficient protocols for biofilm decontamination and tissue preservation. Innovations such as electrolytic cleaning systems and advanced laser modalities are effectively overcoming limitations of mechanical debridement, thus encouraging higher treatment acceptance. The industry's commitment to standardizing these advanced interventions is further demonstrated by collaborative efforts to establish unified, evidence-based guidelines for managing peri-implant diseases.

Market Challenges

A significant challenge impeding market growth is the unpredictability of clinical outcomes associated with current regenerative treatments for peri-implantitis. The absence of a universally standardized protocol creates considerable uncertainty for dental professionals regarding the long-term success of preservation therapies. This lack of confidence often leads clinicians to opt for implant removal rather than investing in or recommending costly and uncertain preservation procedures, thereby suppressing the adoption of advanced market solutions. This clinical uncertainty, compounded by inconsistent insurance reimbursement for peri-implantitis management, frequently biases decision-making toward explantation as a more predictable and financially prudent alternative. This preference limits the revenue potential for diagnostic and regenerative products, even though clinical data from 2025 indicated peri-implantitis affected roughly 22% of patients with dental implants.

Market Trends

The Global Peri-implantitis Market is undergoing transformation driven by key trends, primarily the integration of Artificial Intelligence and digital imaging for early detection, which shifts clinical focus from reactive treatment to predictive monitoring. Cloud-native platforms and AI-driven diagnostics enable unprecedented precision in identifying initial bone loss and soft tissue anomalies, standardizing care and facilitating timely interventions before significant complications arise.

This is supported by the rapid uptake of connected diagnostic ecosystems, as evidenced by Dentsply Sirona's DS Core digital platform exceeding 37,000 unique users. Simultaneously, strategic consolidation through mergers and acquisitions in dental care is establishing robust, vertically integrated networks that streamline the delivery of complex implant therapies. These consolidations aggregate implant systems, digital workflows, and consumables, enhancing operational efficiency, broadening market access, and fostering consistent procedural outcomes, thereby mitigating market fragmentation and solidifying the adoption of standardized implant solutions.

Key Market Players

• Straumann Group
• Dentsply Sirona Inc.
• Zimmer Biomet Holdings, Inc.
• Nobel Biocare Services AG
• Institut Straumann AG
• BioHorizons IPH, Inc.
• Keystone Dental, Inc.
• Thommen Medical AG
• Neoss Limited
• MegaGen Implant Co., Ltd.

Report Scope

In this report, the Global Peri-implantitis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peri-implantitis Market, by Type:

• Non-Surgical
• Surgical

Peri-implantitis Market, by End-User:

• Dental Clinics
• Hospitals

Peri-implantitis Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peri-implantitis Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.